Alignment Healthcare, Inc.

NasdaqGS:ALHC Rapport sur les actions

Capitalisation boursière : US$2.1b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Alignment Healthcare Gestion

Gestion contrôle des critères 3/4

Le PDG Alignment Healthcare's est John Kao, nommé en Jan2014, a un mandat de 10.58 ans. La rémunération annuelle totale est $ 14.30M, composée du salaire de 5.5% et des bonus 94.5%, y compris les actions et options de la société. détient directement 1.66% des actions de la société, d'une valeur de $ 27.61M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 5.4 ans et 9.2 ans.

Informations clés

John Kao

Directeur général

US$14.3m

Rémunération totale

Pourcentage du salaire du PDG5.5%
Durée du mandat du directeur général10.8yrs
Propriété du PDG1.6%
Durée moyenne d'occupation des postes de direction5.5yrs
Durée moyenne du mandat des membres du conseil d'administration9.4yrs

Mises à jour récentes de la gestion

Recent updates

Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Intrinsic Value Is Potentially 73% Above Its Share Price

Oct 14
Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Intrinsic Value Is Potentially 73% Above Its Share Price

Even With A 30% Surge, Cautious Investors Are Not Rewarding Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Performance Completely

Sep 12
Even With A 30% Surge, Cautious Investors Are Not Rewarding Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Performance Completely

Alignment Healthcare (NASDAQ:ALHC) Has Debt But No Earnings; Should You Worry?

Sep 10
Alignment Healthcare (NASDAQ:ALHC) Has Debt But No Earnings; Should You Worry?

Earnings Update: Here's Why Analysts Just Lifted Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$9.55

Aug 04
Earnings Update: Here's Why Analysts Just Lifted Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$9.55

Market Might Still Lack Some Conviction On Alignment Healthcare, Inc. (NASDAQ:ALHC) Even After 27% Share Price Boost

Jul 18
Market Might Still Lack Some Conviction On Alignment Healthcare, Inc. (NASDAQ:ALHC) Even After 27% Share Price Boost

Is Now An Opportune Moment To Examine Alignment Healthcare, Inc. (NASDAQ:ALHC)?

Jul 12
Is Now An Opportune Moment To Examine Alignment Healthcare, Inc. (NASDAQ:ALHC)?

An Intrinsic Calculation For Alignment Healthcare, Inc. (NASDAQ:ALHC) Suggests It's 26% Undervalued

Jun 20
An Intrinsic Calculation For Alignment Healthcare, Inc. (NASDAQ:ALHC) Suggests It's 26% Undervalued

The Market Lifts Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares 37% But It Can Do More

May 30
The Market Lifts Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares 37% But It Can Do More

Is Alignment Healthcare (NASDAQ:ALHC) Weighed On By Its Debt Load?

Apr 19
Is Alignment Healthcare (NASDAQ:ALHC) Weighed On By Its Debt Load?

It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)

Feb 24
It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)

Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?

Jan 18
Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?

Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity

Nov 08
Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity

Alignment Healthcare: Investors Should Align Themselves With Insiders

Oct 05

Alignment Healthcare announces 9M shares secondary offering

Sep 15

Alignment Healthcare completes debt refinancing

Sep 06

Alignment Healthcare: This Next-Generation Medicare Startup Is Fully Valued

Aug 22

Alignment Health Plan plans to expand into three Nevada counties

Jul 20

Alignment Healthcare Grows Revenue But Operating Losses Remain

May 17

Analyse de la rémunération des PDG

Comment la rémunération de John Kao a-t-elle évolué par rapport aux bénéfices de Alignment Healthcare?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

-US$153m

Mar 31 2024n/an/a

-US$157m

Dec 31 2023US$14mUS$787k

-US$148m

Sep 30 2023n/an/a

-US$158m

Jun 30 2023n/an/a

-US$163m

Mar 31 2023n/an/a

-US$146m

Dec 31 2022US$34mUS$730k

-US$150m

Sep 30 2022n/an/a

-US$140m

Jun 30 2022n/an/a

-US$146m

Mar 31 2022n/an/a

-US$179m

Dec 31 2021US$46mUS$675k

-US$195m

Sep 30 2021n/an/a

-US$180m

Jun 30 2021n/an/a

-US$123m

Mar 31 2021n/an/a

-US$70m

Dec 31 2020US$4mUS$657k

-US$23m

Rémunération vs marché: La rémunération totale de John ($USD 14.30M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 5.62M ).

Rémunération et revenus: La rémunération de John a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

John Kao (62 yo)

10.8yrs

Titularisation

US$14,296,476

Compensation

Mr. John E. Kao is Chairman & CEO of Alignment Health Plan of Illinois, Inc. from 2022. Mr. Kao has been Director of Alignment Health Plan of Illinois, Inc. He is the Founder of Alignment Healthcare, Inc....


Équipe de direction

NomPositionTitularisationCompensationPropriété
John Kao
Founder10.8yrsUS$14.30m1.56%
$ 32.6m
Robert Freeman
Chief Financial Officer7.8yrsUS$6.30m0.27%
$ 5.6m
Hyong Kim
Chief Medical Officer1.1yrsUS$3.06m0.072%
$ 1.5m
Dawn Maroney
President of Health Markets & CEO of Health Plan10.8yrsUS$6.46m0.54%
$ 11.3m
Hakan Kardes
Chief Experience Officerless than a yearUS$3.22m0.20%
$ 4.1m
Donald Furman
Co-Founder & Chief Clinical Officerno datapas de données0.80%
$ 16.7m
Charlotte LeBlanc
Chief Accounting Officer and Senior Vice Presidentno datapas de donnéespas de données
Robert Scavo
Chief Information Officer4.1yrspas de données0.10%
$ 2.1m
Christopher Joyce
Chief Legal & Administrative Officer1.2yrspas de données0.026%
$ 551.3k
Andreas Wagner
Chief Human Resources Officerless than a yearpas de donnéespas de données
Sergio Zaldivar
Senior Vice President of Business Operations7.8yrspas de donnéespas de données
Kerry Matsumoto
Senior Vice President of Clinical Product7yrspas de donnéespas de données

5.5yrs

Durée moyenne de l'emploi

56yo

Âge moyen

Gestion expérimentée: L'équipe de direction de ALHC est chevronnée et expérimentée (ancienneté moyenne 5.4 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
John Kao
Founder10.8yrsUS$14.30m1.56%
$ 32.6m
David Hodgson
Independent Director10.8yrsUS$270.00k0.045%
$ 932.7k
Joseph Konowiecki
Independent Chairman of the Board10.8yrsUS$2.25m0.47%
$ 9.8m
N. Vorhoff
Independent Director10.8yrsUS$270.00k0.045%
$ 932.7k
Jacqueline Kosecoff
Independent Director7.8yrsUS$265.63k0.12%
$ 2.6m
Yon Jorden
Independent Director2.8yrsUS$260.00k0.021%
$ 446.2k
Jody Bilney
Independent Director2.8yrsUS$257.50k0.025%
$ 525.3k
Margaret McCarthy
Lead Independent Director3.8yrsUS$280.42k0.043%
$ 904.3k
Mark McClellan
Independent Director10.8yrsUS$250.00k0.16%
$ 3.4m
Melanie Bella
Member of Advisory Board8yrspas de donnéespas de données

9.4yrs

Durée moyenne de l'emploi

68.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de ALHC sont considérés comme expérimentés (ancienneté moyenne 9.3 ans).